Company ITONIS IN

Equities

ITNS

US4657331033

Investment Management & Fund Operators

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Private Equity

Market Closed - OTC Markets Other stock markets 03:54:01 2024-04-24 pm EDT			5-day change	1st Jan Change
0.0006 ^USD	0.00%		0.00%	+50.00%

Itonis Inc. is a holding company. The Company, through the Itonis Pharmaceuticals division, produces and markets over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The Companyâs Emesyl nausea relief product focuses on the general public who suffers from nausea. Emesyl products are available for purchase at https://www.amazon.com and www.Emesyl.com. The Company's subsidiaries include Itonis Holdings, Inc. and Paramount Discoveries, Inc.

Managers	Title	Age	Since
Mark Cheung CEO	Chief Executive Officer	-	11-05-22
Donald Jolly DFI	Director of Finance/CFO	-	11-05-22
Stephen Pidliskey SEC	Corporate Secretary	-	11-05-22

Members of the board	Title	Age	Since
Mark Cheung CEO	Chief Executive Officer	-	11-05-22
Sam Joudeh BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,523,409,834	1,523,409,834 ( 100.00 %)	0	100.00 %

Itonis, Inc.

22600-C Lambert Street Suite 902

92630, Lake Forest

http://www.itonisholdings.com

Financials

Banking & Investment Services

Investment Banking & Investment Services

Investment Management & Fund Operators

Private Equity

	1st Jan change	Capi.
ITONIS IN	+50.00%	0
EQT AB	+3.65%	31.94B
CVC CAPITAL PARTNERS PLC	0.00%	17.45B
ONEX CORPORATION	+6.42%	5.54B
CORPORACIÓN FINANCIERA ALBA, S.A.	-0.42%	3.08B
GOLUB CAPITAL BDC, INC.	+15.23%	2.98B
PETERSHILL PARTNERS PLC	+22.64%	2.9B
BRIDGEPOINT GROUP PLC	-18.98%	2.24B
INVESTCORP CAPITAL PLC	+4.02%	1.23B
RATOS AB	-2.00%	1.07B

Private Equity